Neurology
Standing Up in Multiple Sclerosis (SUMS)
People with severe, progressive Multiple Sclerosis (MS) spend much of their day sitting. In response, secondary physical and psychosocial complications can occur. Effective self-management strategies, feasible to implement within people’s homes, are needed.This pragmatic, multi-centre, definitive, randomised controlled trial (RCT) with blinded outcome assessments at baseline, 20 and 36 weeks post-baseline and full economic evaluation aimed to assess the clinical and cost-effectiveness of a home-based, self-managed, standing frame programme. The intervention group was asked to stand for a minimum of 30 minutes, three times weekly, over 20 weeks.
The study results have been published in The Lancet and can be viewed on the ECTRIMS online library and a short video of participants' experiences of the standing frame can be viewed on the study website.